We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Gives Neos Therapeutics 483 for Relaxed Reviews of Raw Materials
FDA Gives Neos Therapeutics 483 for Relaxed Reviews of Raw Materials
December 6, 2011
Contract manufacturer Neos Therapeutics did not fully establish the reliability of raw materials from suppliers that it used in finished drugs, according to an FDA Form 483.